Pay in 4 interest-free payments of $5.92 Learn more
Ships within 48 hours · Estimated delivery Nov 2 - Nov 7
About the SELECT trial SELECT was a randomised, double-blind, parallel-group, placebo-controlled trial designed to evaluate the efficacy of Wegovy (semaglutide 2.4 mg) versus placebo as an adjunct to standard of care for the prevention of MACE in people with overweight or obesity and established CVD with no prior history of diabetes
& Tian, Z
Continue CPAP use during treatment and work with your sleep specialist to determine when retesting may be appropriate
These parameters may differ for compounded formulations, which are not FDA-approved
US$ 29.40
US$ 26.33
US$ 21.58
US$ 23.13
US$ 20.27
